May 2023 FDA Recall Drug by Ssm Health Care St. Louis Dba Ssm St. Clare Health Center
D-0776-2023 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Ssm Health Care St. Louis Dba Ssm St. Clare Health Center on May 9, 2023 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed in Missouri. and the recall is currently ongoing.

Recall Number: D-0776-2023

Reason for Recall
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Initiated
05-09-2023
Reported
06-07-2023
Quantity
3,232 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SSM Health Care St. Louis DBA SSM St. Clare Health Center
Product was distributed in Missouri.
HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-0600-2

Batch or Lot Expiration Information

Lot# : 20230222-45AB24, BUD: 8/21/2023
Lot# : 20230110-058361, BUD: 7/9/2023
Lot# : 20221208-0F5483, BUD: 6/6/2023
Lot# : 20221109-45BA60, BUD: 5/8/2023
Lot# :20220929-523FD5, BUD: 3/28/2023
Lot# : 20220914-5D5AE0, BUD: 3/13/2023
Lot# : 220502-024, BUD: 10/29/2022
Lot# : 220510-035, BUD: 11/6/2022
Lot# : 220526-015, BUD: 11/22/2022
Lot# : 220811-010, BUD: 2/7/2023